Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD

Suassuna, José H. R.; Das Neves, Fernando C.; Hartney, R. Barrie; Ogg, Chisholm S.; Cameron, J. Stewart
August 1994
Kidney International;Aug1994, Vol. 46 Issue 2, p443
Academic Journal
Immunohistochemical studies on the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. We performed immunohistochemical studies on biopsies of the parietal peritoneal membrane of 33 subjects to investigate whether other cell populations, in addition to mononuclear cells free in the dialysate, might participate in the defense of the peritoneum against microbial invasion during CAPD. Leukocytes were found to concentrate in two areas: a submesothelial layer composed of elongated macrophages displaying activation and maturation markers, and perivascular, less mature macrophages closely associated with T cells and HLA-DR, ICAM-1 and VCAM-1 expressing endothelial cells. Normal mesothelial cells were found to express constitutively the transferrin receptor and the adhesion molecules ICAM-1 and VCAM-1 but not ELAM-1. There were no major differences between normal and uremic subjects, while peritoneal dialysis patients exhibited minor derangements of the submesothelial layer and slight up-regulation of the expression of HLA-DR on endothelial cells. Peritonitis was associated with increased submesothelial cellularity and, particularly, perivascular leukocyte infiltration accompanied by increased expression of HLA-DR and adhesion molecules. Besides mononuclear cells free in the dialysate, this study demonstrates the existence of two additional peritoneal membrane leukocyte populations: submesothelial macrophages, and perivascular macrophages and T cells. It also suggests the existence of a fourth population of intracavitary leukocytes adherent to mesothelial cells. Studies are now necessary to evaluate their exact role in the host defence against peritonitis during CAPD.


Related Articles

  • Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. Dasgupta, Mrinal K.; Larabie, Marlene; Halloran, Philip F. // Kidney International;Aug1994, Vol. 46 Issue 2, p475 

    Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. As peritoneal macrophages require Interferon-γ (IFN-γ) for bacterial lysis, IFN-γ levels were measured in peritoneal dialysis effluents (PDE) by a specific radioimmunoassay. High IFN-γ levels were...

  • Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers? Farhat, Karima; Van Ittersum, Frans Jan; Ter Wee, Piet Marten; Douma, Caroline Ellen // NDT Plus;Oct2008 Supplement 4, Vol. 1, piv46 

    The most important challenge in peritoneal dialysis (PD) is long-term preservation of peritoneal membrane structure and function. Introduction of dialysis fluids into the peritoneal cavity induces changes. These changes are related to duration of dialysis, occurrence of peritonitis and...

  • Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. de Fijter, Carola W. H.; Verbrugh, Henri A.; Oe, Liem P.; Peters, Edith D. J.; van der Meulen, Jan; Donker, Ab J. M.; Verhoef, Jan // Kidney International;Oct1992, Vol. 42 Issue 4, p947 

    Several centers have reported a lower rate of peritonitis among adult patients on continuous cyclic peritoneal dialysis (CCPD) as compared to those undergoing continuous ambulatory peritoneal dialysis (CAPD). Preliminary results of our ongoing prospective randomized study comparing CAPD-Y with...

  • The best dialysis therapy? Results from an international survey among nephrology professionals. Ledebo, Ingrid; Ronco, Claudio // NDT Plus;Dec2008, Vol. 1 Issue 6, p403 

    Background. There is little evidence for superior outcome of one dialysis therapy versus another. Still, nephrologists have to prescribe dialysis every day. It is therefore of interest to ascertain the opinion among nephrology professionals regarding which therapy they consider to be the best...

  • Continuous ambulatory peritoneal dialysis in the United States: A three-year study. Nolph, Karl D.; Cutler, Sidney J.; Steinberg, Seth M.; Novak, Joel W. // Kidney International;Aug1985, Vol. 28 Issue 2, p198 

    This report of the NIH-supported National Continuous Ambulatory Peritoneal Dialysis (CAPD) Registry summarizes data on 7,404 patients treated with CAPD during the three-year period 1981 through 1983, or nearly one-half of patients treated in the USA who were treated with CAPD during this time....

  • Dialysate volume measurements required for determining peritoneal solute transport. Leypoldt, John K.; Pust, Andreas H.; Frigon, Ronald P.; Henderson, Lee W. // Kidney International;Aug1988, Vol. 34 Issue 2, p254 

    Solute transport parameters for the peritoneal mem- brant have been previously determined using dialysate volumes measured by the indicator dilution method. Recent work has shown that the indicator dilution volume (IDV) exceeds true dialysate volume (TV) because the indicator or index solute is...

  • Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Davies, Simon J. // Kidney International;Dec2004, Vol. 66 Issue 6, p2437 

    Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.Background.Time on treatment is associated with a greater risk of impaired ultrafiltration (UF) in peritoneal dialysis (PD) patients. In addition to increasing solute transport, a...

  • Influence of exchange volume and dialysate flow rate on solute clearance in peritoneal dialysis. Robson, M.; Oreopoulos, D. G.; Izatt, S.; Ogilvie, R.; Rapoport, A.; de Veber, G. A. // Kidney International;Nov1978, Vol. 14 Issue 5, p486 

    To find the ideal dialysate flow rate and exchange volume for use in long-term peritoneal dialysis, 10 patients were studied over a period of 1.5 yr. Exchange volumes of 1 or 2 liters and dialysate flow rates of 1. 2, 3, 4, and 6 liters/hr were tested. Dextrose concentration remained constant at...

  • Peritoneal dialysis and loss of proteins: A review. Dulaney, John T.; Hatch Jr., Fred E. // Kidney International;Sep1984, Vol. 26 Issue 3, p253 

    Discusses the benefits and limitations of peritoneal dialysis (PD). Loss of proteins during PD; Improvement in immunodeficiency; Interactions between drugs and peritoneal transport.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics